Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 12Unknown 7Recruiting 4Enrolling by invitation 3Terminated 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 5Gastrointestinal 5Breast 4Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Genitourinary 2Other 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Lymphoma 369Lymphoma, Non-Hodgkin 346Leukemia, Lymphocytic, Chronic, B-Cell 321Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Lymphoma, Large B-Cell, Diffuse 244Lymphoma, Follicular 236Leukemia 197Hodgkin Disease 170Lymphoma, Mantle-Cell 164Leukemia, Myeloid, Acute 160Multiple Myeloma 134Myelodysplastic Syndromes 130Recurrence 125Burkitt Lymphoma 123Lymphoma, B-Cell, Marginal Zone 120Lymphoma, T-Cell, Cutaneous 92Mycosis Fungoides 82Neoplasms 81Lymphoma, B-Cell 81Waldenstrom Macroglobulinemia 74Leukemia, Myelogenous, Chronic, BCR-ABL Positive 70Sezary Syndrome 67Lymphoma, Large-Cell, Immunoblastic 65Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 57Lymphoma, Large-Cell, Anaplastic 54Neoplasms, Plasma Cell 52Myeloproliferative Disorders 52Primary Myelofibrosis 46Hematologic Neoplasms 44Blast Crisis 43

Interventions

Mindfulness-Based Stress Reduction 1Midazolam 1Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Anxiety Disorders × Lymphoid × Clear all
NCT03043430 2023-04-25

Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients

Brooke Army Medical Center

Phase 4 Terminated
10 enrolled
LymphoidOther hematologic neoplasm

Anxiety Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03174808 2019-11-27

Mindfulness Interventions and Cutaneous T Cell Lymphoma (CTCL)

Yale University

Phase NA Terminated
3 enrolled
DermatologicLymphoid

Anxiety Disorders, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡